References
1. Department of Health and Social Care. Optimising the COVID-19 vaccination programme for maximum short-term impacthttps://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement/optimising-the-covid-19-vaccination-programme-for-maximum-short-term-impact
2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med2020;383(27):2603–15. DOI: 10.1056/NEJMoa2034577
3. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397(10269):99–111. DOI:https://doi.org/10.1016/S0140-6736(20)32661-1
4. Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLlife 2020;9. DOI: 10.7554/eLife.58728
5. Cooper DJ, Lear S, Watson L, et al. A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital. medRxiv 2020. DOI: https://doi.org/10.1101/2020.11.03.20220699
Cambridge COVID-19 Collaboration
Amy Amory, Steve Baker, Emma Bateman, Aklima Begum, Moushima Begum, John Bradley, Michael Brennan, Helen Burn, Caroline Crofts, Sharon Dawson, Gordon Dougan, Renny Feather, Louise Free, Katie Friel, Claire Gildea, Ian Goodfellow, Lizz Grimwade, Ravi Gupta, Susan Hall, Sophie Hannan, James Hayes, Aleksandra Hosaja, Lidia James, Jill Jardin, Nathalie Kingston, Paul A. Lyons, Patrick H. Maxwell, Sue Mott, Sarah Mugavin, Joyce Mwiya, Ravi Prakash Nallattil, Willem H. Ouwehand, Elle Page, Marina Perez, Natalie Quinnell, Caroline Saunders, Kenneth G.C. Smith, Maria Stafford, Charlotte Summers, Despiona Tatsi, James E.D. Thaventhiran, Sharon Thomas Johnson, Mark Toshner, Lesley Turner, Kate Wall, Ben Warne, Karis Watson, Jo Wright